OM insider buying and SEC filings, explained
Outset Medical, Inc. · CIK 1484612
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Home Dialysis Plus, Ltd.
Insider activity in the last 12 months
Bought
$870K
Insiders who bought
1
Sold (not marked 10b5-1)
$369K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 1–2, 2026 | Purchase (code P) | Braden Michael Leonard (10% owner) bought 244,909 shares indirectly (by entity) between Oct 1 and Oct 2 at about $3.55 ($870K), reported as a purchase (code P). Holdings by entity up 10% to 2,764,610 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 5, 2026, 7:24 PM ET |
| Aug 17, 2026 | Sale | Leslie Trigg (CEO and Director) sold 3,437 shares at $4.39 ($15K). Holdings down 2% to 194,597 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 18, 2026 |
| Aug 17, 2026 | Sale | John L. Brottem (General Counsel) sold 2,632 shares at $4.39 ($12K). Holdings down 3% to 87,475 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 18, 2026 |
| Aug 17, 2026 | Sale | Renee Gaeta (CFO) sold 4,543 shares at $4.39 ($20K). Holdings down 2% to 180,840 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 18, 2026 |
| Jun 3, 2026 | Sale | Renee Gaeta (CFO) sold 17,672 shares at $4.94 ($87K). Holdings down 13% to 113,753 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 5, 2026 |
| May 15, 2026 | Sale | Leslie Trigg (CEO and Director) sold 3,445 shares at $3.70 ($13K). Holdings down 3% to 98,874 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 15, 2026 | Sale | Marc Nash (EVP Operations R&D & Service) sold 1,582 shares at $3.70 ($6K). Holdings down 4% to 38,393 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 15, 2026 | Sale | John L. Brottem (General Counsel) sold 2,638 shares at $3.70 ($10K). Holdings down 8% to 30,277 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| Feb 17, 2026 | Sale | Marc Nash (EVP Operations R&D & Service) sold 1,817 shares at $3.35 ($6K). Holdings down 4% to 39,988 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 19, 2026 |
| Feb 17, 2026 | Sale | John L. Brottem (General Counsel) sold 2,842 shares at $3.35 ($10K). Holdings down 8% to 32,935 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 19, 2026 |
| Feb 17, 2026 | Sale | Leslie Trigg (CEO and Director) sold 3,361 shares at $3.35 ($11K). Holdings down 3% to 102,342 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 19, 2026 |
| Jan 20–21, 2026 | Sale | Marc Nash (EVP Operations R&D & Service) sold 6,355 shares between Jan 20 and Jan 21 at about $5.10 ($32K). Holdings down 13% to 41,805 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 21, 2026 |
| Jan 20–21, 2026 | Sale | John L. Brottem (General Counsel) sold 10,494 shares between Jan 20 and Jan 21 at about $5.11 ($54K). Holdings down 23% to 35,777 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 21, 2026 |
| Jan 20–21, 2026 | Sale | Leslie Trigg (CEO and Director) sold 13,914 shares between Jan 20 and Jan 21 at about $5.11 ($71K). Holdings down 12% to 105,703 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 21, 2026 |
| Jan 7, 2026 | Sale | Marc Nash (EVP Operations R&D & Service) sold 108 shares at $4.27 ($461). Holdings down <1% to 48,160 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Jan 7, 2026 | Sale | John L. Brottem (General Counsel) sold 224 shares at $4.27 ($956). Holdings down <1% to 46,271 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Jan 7, 2026 | Sale | Leslie Trigg (CEO and Director) sold 1,795 shares at $4.27 ($8K). Holdings down 1% to 119,617 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Dec 1, 2025 | Sale | Karen Drexler (Director) sold 1,548 shares at $4.37 ($7K). Holdings down 13% to 10,650 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 2, 2025 |
| Nov 17, 2025 | Sale | Leslie Trigg (CEO and Director) sold 916 shares at $4.60 ($4K). Holdings down 1% to 121,412 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 18, 2025 |
| Nov 17, 2025 | Sale | Marc Nash (EVP Operations R&D & Service) sold 247 shares at $4.60 ($1K). Holdings down 1% to 48,268 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 18, 2025 |
| Nov 17, 2025 | Sale | John L. Brottem (General Counsel) sold 388 shares at $4.60 ($2K). Holdings down 1% to 46,495 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 18, 2025 |
13 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow OM in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.